Search
for
Sort by
Research 61–90 of 1000+
- Current understanding and treatment of sex hormone-related hair diseases
- The Treatment of Hyperandrogenism with Oral Contraceptives
- Targeting receptor–regulator interactions
- The Evaluation and Management of Hirsutism
- Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
- Engineered Exosomes Co-Delivering EGF and FGF Ameliorate Androgenetic Alopecia in a Mouse Model
- Polycystic Ovary Syndrome
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- The role of androgen therapy
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- The therapeutic use of androgens in women
- What is the Rationale for Androgen Therapy for Women?
- Chapter 23. Therapeutic Control of Androgen Action
- The role of androgens in hormone replacement therapy
- Anti-androgen therapy in dermatology: a review
- Androgen replacement therapy in women
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Androgen receptor: A promising therapeutic target in breast cancer
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Development of fluridil, a topical suppressor of the androgen receptor in androgenetic alopecia
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- Gonadal Suppressive and Cross‐Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults
- Androgen excess is the key element in polycystic ovary syndrome
- Muscle pain in a woman with congenital adrenal hyperplasia due to 21-hydroxylase deficiency resolved with testosterone therapy. A case report with 10 years of follow-up
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women